These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33609752)

  • 1. A Tuft Cell-Like Signature Is Highly Prevalent in Thymic Squamous Cell Carcinoma and Delineates New Molecular Subsets Among the Major Lung Cancer Histotypes.
    Yamada Y; Simon-Keller K; Belharazem-Vitacolonnna D; Bohnenberger H; Kriegsmann M; Kriegsmann K; Hamilton G; Graeter T; Preissler G; Ott G; Roessner ED; Dahmen I; Thomas RK; Ströbel P; Marx A
    J Thorac Oncol; 2021 Jun; 16(6):1003-1016. PubMed ID: 33609752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. POU2F3 beyond thymic carcinomas: expression across the spectrum of thymomas hints to medullary differentiation in type A thymoma.
    Yamada Y; Sugimoto A; Hoki M; Yoshizawa A; Hamaji M; Date H; Haga H; Marx A
    Virchows Arch; 2022 Apr; 480(4):843-851. PubMed ID: 34988657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary cancers across different histotypes share hybrid tuft cell/ionocyte-like molecular features and potentially druggable vulnerabilities.
    Yamada Y; Belharazem-Vitacolonnna D; Bohnenberger H; Weiß C; Matsui N; Kriegsmann M; Kriegsmann K; Sinn P; Simon-Keller K; Hamilton G; Graeter T; Preissler G; Ott G; Schölch S; Nakajima N; Yoshizawa A; Haga H; Date H; Thomas RK; Petrini I; Giaccone G; Ströbel P; Marx A
    Cell Death Dis; 2022 Nov; 13(11):979. PubMed ID: 36402755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas.
    Girard N; Shen R; Guo T; Zakowski MF; Heguy A; Riely GJ; Huang J; Lau C; Lash AE; Ladanyi M; Viale A; Antonescu CR; Travis WD; Rusch VW; Kris MG; Pao W
    Clin Cancer Res; 2009 Nov; 15(22):6790-9. PubMed ID: 19861435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An exploratory study for tuft cells in the breast and their relevance in triple-negative breast cancer: the possible relationship of SOX9.
    Yamada Y; Simon R; Iwane K; Nakanishi Y; Takeuchi Y; Yoshizawa A; Takada M; Toi M; Haga H; Marx A; Sauter G
    BMC Cancer; 2023 May; 23(1):438. PubMed ID: 37179317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histogenetic and disease-relevant phenotypes in thymic epithelial tumors (TETs): The potential significance for future TET classification.
    Yamada Y
    Pathol Int; 2023 Jul; 73(7):265-280. PubMed ID: 37278579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer.
    Huang YH; Klingbeil O; He XY; Wu XS; Arun G; Lu B; Somerville TDD; Milazzo JP; Wilkinson JE; Demerdash OE; Spector DL; Egeblad M; Shi J; Vakoc CR
    Genes Dev; 2018 Jul; 32(13-14):915-928. PubMed ID: 29945888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Classification of Extrapulmonary Neuroendocrine Carcinomas With Emphasis on POU2F3-positive Tuft Cell Carcinoma.
    Koh J; Kim H; Moon KC; Lee C; Lee K; Ryu HS; Jung KC; Jeon YK
    Am J Surg Pathol; 2023 Feb; 47(2):183-193. PubMed ID: 36253891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic Targets.
    Enkner F; Pichlhöfer B; Zaharie AT; Krunic M; Holper TM; Janik S; Moser B; Schlangen K; Neudert B; Walter K; Migschitz B; Müllauer L
    Pathol Oncol Res; 2017 Jul; 23(3):551-564. PubMed ID: 27844328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical KIT (CD117) expression in thymic epithelial tumors.
    Nakagawa K; Matsuno Y; Kunitoh H; Maeshima A; Asamura H; Tsuchiya R
    Chest; 2005 Jul; 128(1):140-4. PubMed ID: 16002927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymic Carcinoma: Unraveling Neuroendocrine Differentiation and Epithelial Cell Identity Loss.
    Yamada Y; Iwane K; Nakanishi Y; Haga H
    Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuft cell-like carcinomas: novel cancer subsets present in multiple organs sharing a unique gene expression signature.
    Yamada Y; Bohnenberger H; Kriegsmann M; Kriegsmann K; Sinn P; Goto N; Nakanishi Y; Seno H; Chigusa Y; Fujimoto M; Minamiguchi S; Haga H; Simon R; Sauter G; Ströbel P; Marx A
    Br J Cancer; 2022 Nov; 127(10):1876-1885. PubMed ID: 35999270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of gene mutations in KIT-positive thymic epithelial tumors.
    Tsuchida M; Umezu H; Hashimoto T; Shinohara H; Koike T; Hosaka Y; Eimoto T; Hayashi JI
    Lung Cancer; 2008 Dec; 62(3):321-5. PubMed ID: 18486988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational status of EGFR and KIT in thymoma and thymic carcinoma.
    Yoh K; Nishiwaki Y; Ishii G; Goto K; Kubota K; Ohmatsu H; Niho S; Nagai K; Saijo N
    Lung Cancer; 2008 Dec; 62(3):316-20. PubMed ID: 18448188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokeratins in normal thymus and thymic epithelial tumors.
    Fukai I; Masaoka A; Hashimoto T; Yamakawa Y; Mizuno T; Tanamura O
    Cancer; 1993 Jan; 71(1):99-105. PubMed ID: 7677978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and Prognostic Significances of SOX9 in Thymic Epithelial Tumor.
    Yuan X; Huang L; Luo W; Zhao Y; Nashan B; Yu F; Liu Y
    Front Oncol; 2021; 11():708735. PubMed ID: 34778027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetic characteristics of thymic epithelial tumors with distinct histological subtypes.
    Yang J; Zhang B; Guan W; Fan Z; Pu X; Zhao L; Jiang W; Cai W; Quan X; Miao S; Nie L; He L
    Cancer Med; 2023 May; 12(9):10575-10586. PubMed ID: 36916520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. POU2F3-Expressing Small Cell Lung Carcinoma and Large Cell Neuroendocrine Carcinoma Show Morphologic and Phenotypic Overlap.
    Jimbo N; Ohbayashi C; Takeda M; Fujii T; Mitsui S; Tsukamoto R; Tanaka Y; Itoh T; Maniwa Y
    Am J Surg Pathol; 2024 Jan; 48(1):4-15. PubMed ID: 37904277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular landscape of thymic epithelial tumors.
    Prays J; Ortiz-Villalón C
    Semin Diagn Pathol; 2022 Mar; 39(2):131-136. PubMed ID: 34272124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of POU2F3 Transcription Factor and POU2AF2, POU2F3 Coactivator, in Tuft Cell-like Carcinoma and Other Tumors.
    Kaczorowski M; Ylaya K; Chłopek M; Lasota J; Miettinen M
    Am J Surg Pathol; 2025 Jan; 49(1):62-72. PubMed ID: 39319626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.